Read all the information presented below. When ready select the "View Program" tab above.
To receive credits, participants must review the program materials in their entirety and complete the online post examination and evaluation. CE credits require a post examination score of 80% or higher.
System Hardware/Software and Internet Connection Requirements
The following information is provided for your reference in conjunction with review of this program.
General System and Internet Requirements: Speakers or Headphones, High Speed Internet connection, Wireless 4G and 5G,
Web browsers: Chrome (v 7.5.288 or higher), Firefox (v72 or higher), Safari (v10.1.x or higher) Edge (v 85.0 or higher) and Internet Explorer (7.x or higher)
Operating Systems: Windows 8 or higher, (MS Surface and other MS mobile devices compatible), MAC OSX 10.3 or higher, Mac iOS 5.0 or higher (iPad, iPhone compatible), Android 4.3 or higher (most Android mobile devices compatible).
Since the 1990’s, multi-patient contrast administration has been available in the form of the Pharmacy Bulk Package (PBP), which is still offered by several contrast vendors. The FDA required that all related Prescribing Information (PI) sheets for the PBP include specific directions for the dispensing of the contrast from the PBP container. The PI language describes withdrawing the contrast from the bottle in a suitable work area, specifically “a laminar flow hood, using aseptic techniques”. However, this method is not possible in most CT Suites, as laminar flow hoods are generally located in the Pharmacy, not the CT suite.
Therefore, during the last decade, regulators have begun to have concerns about the use of PBP. In 2009, The Joint Commission began citing imaging providers who were using PBP to fill power injector syringes in what they considered an unsuitable work area, as described in the manufacturer’s PBP guidelines for the dispensing of contrast.
This Expert Forum will review the steps taken by the contrast media industry and the FDA to develop a safe and compliant solution for multi-patent contrast administration in CT. This solution is now available as the Imaging Bulk Package (IBP) which is approved for use in the CT Suite. This panel will also share their comprehensive process for incorporating IBP into their clinical practice.
Following the presentations questions from the audience were addressed in a moderated Q&A session.
Initial CE Effective Date: January 1, 2019
Renewal CE Effective Date: March 4, 2021
CE Expiration Date: March 31, 2022
Format: Self Instructional - Audio Visual with Slides
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour
This program is intended for: Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
Upon completion of this CME activity the healthcare provider should be able to:
- Describe why Pharmacy Bulk Package(PBP) utilization in the CT Suite, is considered unsafe.
- Understand the difference between Pharmacy Bulk Package (PBP) and Imaging Bulk Package (IBP) and define which is approved by the FDA for multi-patient use in the CT.
- Discuss the clinical and economic benefits of multi-patient contrast administration using Imaging Bulk Package(IBP).
No special educational preparation is required for this CE activity!
Stuart E. Mirvis, MD, FACR
University of Maryland School of Medicine
Dr. Stuart Mirvis is a radiologist in Baltimore, Maryland and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Maryland Medical Center Midtown Campus.
He received his medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years. He is one of 91 doctors at University of Maryland Medical Center and one of 54 at University of Maryland Medical Center Midtown Campus who specialize in Radiology.
James Sancrant, DO
Dr. Sancrant is the Chairman for Clinical Operations for Triad Radiology Associates, Winston Salem, North Carolina.
Triad Radiology is private practice Radiology Group affiliated with multiple hospitals and outpatient imaging centers in NC and SC. This subspecialty Radiology practice has 47 Radiologists who support Novant Health’s Winston Salem market. This includes their flag ship medical facility, Novant Health’s Forsyth Medical Center. A 900 bed, Regional Cancer Center which has the second busiest ED volume in North Carolina.
Dr. Sancrant received his medical degree from Ohio University College of Osteopathic Medicine and completed his Radiology Residency in 2006 and MSK Fellowship in 2012, both at Wake Forest School of Medicine. He has been in clinical practice for approximately 20 years.
Vannessa Berrios, RPh
Pharmacy & Regulatory Specialist of USP
Vannessa Berrios RPh, is the Novant Health Pharmacy Regulatory Specialist of USP. In this role she provides guidance in regulatory requirements for the compounding of medications and ensures the compliance of USP standards across Novant Health. Other responsibilities include the development of policies and procedures related to IV rooms and compounding practices and collaborates in standardization initiatives.
Vannessa graduated from the University of Puerto Rico-School of Pharmacy in 1994 and joined Novant Health in 2006.
Rhonda Mull, RN, BSN, MHA, CIC
Director of Infection Prevention
Rhonda Mull RN, BSN, MHA, CIC is the Novant Health Market Director of Infection Prevention for Charlotte and Northern Virginia markets. In this role, she provides oversite for infection prevention practices and regulatory requirements for inpatient and outpatient services for Novant Health. Corporately Novant Health Infection Prevention strives to develop and standardize best practices. Preventing infection is everyone’s responsibility!
Rhonda graduated from the University of North Carolina – Charlotte in 1989 with a BSN degree, and Pfeiffer University with an MHA in 2007. She joined Novant in 2014.
Stephanie Allen, MBA, RT(R)(MR), CJCP
Manager, Accreditation & Regulatory
Stephanie Allen, MBA, RT(R)(MR), CJCP, is a manager of accreditation and regulatory for Novant Health. In this role, she provides guidance for accreditation, certification and regulatory compliance and survey activities in ambulatory and imaging departments across Novant Health.
Stephanie holds a BS in Radiologic Science from the University of North Carolina and earned her MBA from East Carolina University. She joined Novant in 2011.
Stuart E. Mirvis, MD, FACR
has nothing to disclose.
James Sancrant, DO
has nothing to disclose.
Vannessa Berrios, RPh has nothing to disclose.
Rhonda Mull, RN, BSN, MHA, CIC has nothing to disclose.
Stephanie Allen, MBA, RT(R)(MR), CJCP has nothing to disclose.
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.
This course meets all CRA renewal credit criteria and has been approved for one (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
Method of Participation/Criteria for Success
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.